We analyzed the association between leptin levels and steatotic liver disease (SLD) in 636 participants from the screening population of the SAKKOPI registry (2007–2020) who underwent metabolic phenotyping, leptin measurement, and liver assessment including ultrasound, controlled attenuation parameter (CAP), and transient elastography (kPa). This evidence concerns the gene LEP and liver disorder.